Paradigm Biopharmaceuticals Ltd.ASX: PAR

PARs European Patent Granted for Bone Marrow Edema Lesions

Jan 16, 2018 at 2:52 AM UTC · Issued by Paradigm Biopharmaceuticals Ltd.

Paradigm Biopharmaceuticals Ltd has released a press release.

View Attachment